Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 335-347
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.335
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.335
Figure 3 Kaplan-Meier overall survival analysis.
A: Kaplan-Meier overall survival (OS) analysis of colorectal adenocarcinoma patients based on human epidermal growth factor receptor 2 (HER2) expression status (as determined by fluorescence in situ hybridization); B: Kaplan-Meier OS analysis of tubular adenocarcinoma patients age ≤ 65 based on HER2 expression status; C: Kaplan-Meier OS analysis of tubular adenocarcinoma patients with moderate-poor differentiation and age ≤ 65 based on HER2 expression status; D: Kaplan-Meier overall survival analysis of tubular adenocarcinoma patients with stage T2-4 tumors and age ≤ 65 based on HER2 expression status. HER2: Human epidermal growth factor receptor 2; FISH: Fluorescence in situ hybridization.
- Citation: Wang XY, Zheng ZX, Sun Y, Bai YH, Shi YF, Zhou LX, Yao YF, Wu AW, Cao DF. Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas. World J Gastrointest Oncol 2019; 11(4): 335-347
- URL: https://www.wjgnet.com/1948-5204/full/v11/i4/335.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i4.335